2025.06.13
Events
Article quoted from:
G&E Biotech Successfully Holds 2025 Annual Shareholders’ Meeting
We sincerely thank all our guests for their valuable insights and unwavering support.
G&E Herbal Biotech Chairman Dr. Kou-Wha, Kuo (formerly Biochemistry Professor at Kaohsiung Medical University) shared updates on the SR-100 product series and R&D progress during the meeting:
- Presented achievements including SR-100 Smile Cream, SR-100 SolaVision, signature Eye Care Products, and functional skincare products
- Achieving solid revenue results with resounding shareholder endorsement
- Continued advancement of the internationally innovative development of the Malignant Ascites Injection New Drug (SR-T100)